11
total announcements
530019.BO · 15 min delayed
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has published a newspaper advertisement regarding the notice of its 48th Annual General Meeting, e-voting, record date, and final dividend information.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced a potential deduction of tax at source (TDS) on the final dividend for FY 2025-26, subject to approval by shareholders at the ensuing AGM. The company has also provided details on the procedures to be followed by shareholders for submission of relevant forms and documents.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has dispatched letters to shareholders whose email IDs are not registered, providing a weblink to access the Annual Report for FY 2025-26 and Notice of the 48th Annual General Meeting along with TDS Communication.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has released its Business Responsibility and Sustainability Report for the financial year 2025-26, as required by SEBI regulations.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced its 48th Annual General Meeting (AGM) to be held on August 26, 2026, through video conferencing. The meeting will consider the audited financial statements for the year ended March 31, 2026, and re-appointment of directors, including Mr. Arjun Shanker Bhartia and Mr. Hari S. Bhartia. The company also proposes to declare a dividend of ₹5 per equity share.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced its 48th Annual General Meeting (AGM) to be held on August 26, 2026, through Video Conferencing/Other Audio-Visual Means (VC/OAVM). The AGM notice and annual report for the financial year 2025-26 have been sent to all members whose email addresses are registered with the company/RTA/depository participant(s). The company has provided the facility to vote by electronic means (remote e-voting as well as e-voting at the AGM) to the members who are holding shares on the cut-off date. The remote e-voting will commence at 9:00 a.m. (IST) on Sunday, August 23, 2026, and end at 5:00 p.m. (IST) on Tuesday, August 25, 2026.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced its 48th Annual General Meeting (AGM) to be held on August 26, 2026, through video conferencing. The company has also released its annual report for the financial year 2025-26 and has proposed a dividend of ₹5 per equity share.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has submitted copies of newspaper advertisements relating to notice to shareholders regarding the transfer of equity shares/dividend to the Investor Education and Protection Fund Authority.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd has announced a company update under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the transfer of unclaimed dividend and equity shares to the Investor Education and Protection Fund (IEPF). The company has sent a communication to shareholders informing them of the transfer and providing details of the unpaid dividend and shares to be transferred. Shareholders are requested to claim the unpaid dividend by making an application to Alankit Assignments Limited before August 31, 2026, to avoid the transfer of shares to the IEPF.
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd announced the 48th Annual General Meeting (AGM) scheduled for August 26, 2026, through video conferencing. The notice and annual report for 2025-26 will be sent to shareholders via email and available on the company's website.